304 related articles for article (PubMed ID: 9440686)
1. A new classification for HIV-1.
Berger EA; Doms RW; Fenyö EM; Korber BT; Littman DR; Moore JP; Sattentau QJ; Schuitemaker H; Sodroski J; Weiss RA
Nature; 1998 Jan; 391(6664):240. PubMed ID: 9440686
[No Abstract] [Full Text] [Related]
2. Cytokine modulation of HIV-1 chemokine receptor expression.
Landay AL; Patterson B; Andersson J
Nat Med; 1999 Jun; 5(6):592-3. PubMed ID: 10371480
[No Abstract] [Full Text] [Related]
3. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India.
Cecilia D; Kulkarni SS; Tripathy SP; Gangakhedkar RR; Paranjape RS; Gadkari DA
Virology; 2000 Jun; 271(2):253-8. PubMed ID: 10860879
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 tropism, disease progression, and clinical management.
Burger H; Hoover D
J Infect Dis; 2008 Oct; 198(8):1095-7. PubMed ID: 18783314
[No Abstract] [Full Text] [Related]
5. HIV's response to a CCR5 inhibitor: I'd rather tighten than switch!
Farber JM; Berger EA
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):1749-51. PubMed ID: 11854476
[No Abstract] [Full Text] [Related]
6. Co-receptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient?
Lathey JL; Brambilla D; Goodenow MM; Nokta M; Rasheed S; Siwak EB; Bremer JW; Huang DD; Yi Y; Reichelderfer PS; Collman RG
J Leukoc Biol; 2000 Sep; 68(3):324-30. PubMed ID: 10985247
[TBL] [Abstract][Full Text] [Related]
7. Determination of co-receptor usage of HIV-1.
Schuitemaker H; Kootstra NA
Methods Mol Biol; 2005; 304():327-32. PubMed ID: 16061986
[TBL] [Abstract][Full Text] [Related]
8. HIV chemokine receptor inhibitors as novel anti-HIV drugs.
Princen K; Schols D
Cytokine Growth Factor Rev; 2005 Dec; 16(6):659-77. PubMed ID: 16005254
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.
Garrido C; Roulet V; Chueca N; Poveda E; Aguilera A; Skrabal K; Zahonero N; Carlos S; García F; Faudon JL; Soriano V; de Mendoza C
J Clin Microbiol; 2008 Mar; 46(3):887-91. PubMed ID: 18199789
[TBL] [Abstract][Full Text] [Related]
10. HIV type 1 tropism and inhibitors of viral entry: clinical implications.
Weber J; Piontkivska H; Quiñones-Mateu ME
AIDS Rev; 2006; 8(2):60-77. PubMed ID: 16848274
[TBL] [Abstract][Full Text] [Related]
11. Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5.
Lapham CK; Zaitseva MB; Lee S; Romanstseva T; Golding H
Nat Med; 1999 Mar; 5(3):303-8. PubMed ID: 10086386
[TBL] [Abstract][Full Text] [Related]
12. HIV coreceptor phenotyping in the clinical setting.
Low AJ; Swenson LC; Harrigan PR
AIDS Rev; 2008; 10(3):143-51. PubMed ID: 18820716
[TBL] [Abstract][Full Text] [Related]
13. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
14. Stable coreceptor usage of HIV in patients with ongoing treatment failure on HAART.
Lehmann C; Däumer M; Boussaad I; Sing T; Beerenwinkel N; Lengauer T; Schmeisser N; Wyen C; Fätkenheuer G; Kaiser R
J Clin Virol; 2006 Dec; 37(4):300-4. PubMed ID: 17005445
[TBL] [Abstract][Full Text] [Related]
15. The role of the CD4 receptor versus HIV coreceptors in envelope-mediated apoptosis in peripheral blood mononuclear cells.
Arthos J; Cicala C; Selig SM; White AA; Ravindranath HM; Van Ryk D; Steenbeke TD; Machado E; Khazanie P; Hanback MS; Hanback DB; Rabin RL; Fauci AS
Virology; 2002 Jan; 292(1):98-106. PubMed ID: 11878912
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
[TBL] [Abstract][Full Text] [Related]
17. Coreceptor switching in HIV-1 subtype B and subtype C.
Mugwagwa T; Witten G
Bull Math Biol; 2007 Jan; 69(1):55-75. PubMed ID: 17086370
[TBL] [Abstract][Full Text] [Related]
18. [Human immunodeficiency virus (HIV) co-receptors expression in mononuclear leucocytes (ML) of HIV+ patients].
Belmonte L; de Elizalde de Bracco MM; Ruibal-Ares B
Medicina (B Aires); 2001; 61(5 Pt 2):670-2. PubMed ID: 12058586
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART.
Soulié C; Marcelin AG; Ghosn J; Amellal B; Assoumou L; Lambert S; Duvivier C; Costagliola D; Katlama C; Calvez V
AIDS; 2007 Oct; 21(16):2243-5. PubMed ID: 18090053
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 coreceptor usage determination in clinical isolates using clonal and population-based genotypic and phenotypic assays.
Van Baelen K; Vandenbroucke I; Rondelez E; Van Eygen V; Vermeiren H; Stuyver LJ
J Virol Methods; 2007 Dec; 146(1-2):61-73. PubMed ID: 17640743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
